510(k) K912391
K912391 is an FDA 510(k) premarket notification submitted by Orion Corp. for the device "RUBALEX, MODIFICATION". The FDA issued a decision of Substantially Equivalent on May 4, 1992. The device falls under product code LQN (Latex Agglutination Assay, Rubella), a Class II device regulated under 21 CFR 866.3510. Orion Corp. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 4, 1992
- Date Received
- May 24, 1991
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Latex Agglutination Assay, Rubella
- Device Class
- Class II
- Regulation Number
- 866.3510
- Review Panel
- MI
- Submission Type